WallStreetZenWallStreetZen

NASDAQ: MGNX
Macrogenics Inc Stock Forecast, Predictions & Price Target

Analyst price target for MGNX

Based on 7 analysts offering 12 month price targets for Macrogenics Inc.
Min Forecast
$12.00-42.08%
Avg Forecast
$17.00-17.95%
Max Forecast
$24.00+15.83%

Should I buy or sell MGNX stock?

Based on 7 analysts offering ratings for Macrogenics Inc.
Strong Buy
Strong Buy
5 analysts 71.43%
Buy
1 analysts 14.29%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MGNX stock forecasts and price targets.

MGNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-04
lockedlocked$00.00+00.00%2024-02-29Find Out Why
lockedlocked$00.00+00.00%2024-02-14
lockedlocked$00.00+00.00%2024-01-24
lockedlocked$00.00+00.00%2023-12-20Find Out Why
Stifel Nicolaus
Top 19%
82
Strong BuyReiterates$17.00-17.95%2023-11-27
Guggenheim
Top 16%
85
Strong BuyUpgrades$12.00-42.08%2023-11-07

1 of 1

Forecast return on equity

Is MGNX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.53%

Forecast return on assets

Is MGNX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MGNX revenue forecast

What is MGNX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$90.2M-25.53%
Avg 2 year Forecast
$329.1M+171.72%
Avg 3 year Forecast
$105.7M-12.75%
MGNX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MGNX earnings growth forecast

How is MGNX forecast to perform vs Biotechnology companies and vs the US market?
Company
36.72%
Industry
6.7%
Market
22.15%
MGNX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MGNX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MGNX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MGNX revenue growth forecast

How is MGNX forecast to perform vs Biotechnology companies and vs the US market?
Company
-4.44%
Industry
45.3%
Market
10.84%
MGNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MGNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MGNX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MGNX$20.72$17.00-17.95%Strong Buy
ETNB$13.77$24.75+79.74%Strong Buy
AMLX$19.14$36.40+90.18%Strong Buy
ADMA$5.72$8.00+39.86%Strong Buy
SYRE$34.97$31.25-10.64%Strong Buy

Macrogenics Stock Forecast FAQ

Is Macrogenics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: MGNX) stock is to Strong Buy MGNX stock.

Out of 7 analysts, 5 (71.43%) are recommending MGNX as a Strong Buy, 1 (14.29%) are recommending MGNX as a Buy, 1 (14.29%) are recommending MGNX as a Hold, 0 (0%) are recommending MGNX as a Sell, and 0 (0%) are recommending MGNX as a Strong Sell.

If you're new to stock investing, here's how to buy Macrogenics stock.

What is MGNX's revenue growth forecast for 2024-2026?

(NASDAQ: MGNX) Macrogenics's forecast annual revenue growth rate of -4.44% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Macrogenics's revenue in 2024 is $121,128,000.On average, 3 Wall Street analysts forecast MGNX's revenue for 2024 to be $5,595,242,208, with the lowest MGNX revenue forecast at $3,695,094,158, and the highest MGNX revenue forecast at $8,519,124,251. On average, 1 Wall Street analysts forecast MGNX's revenue for 2025 to be $20,415,751,891, with the lowest MGNX revenue forecast at $20,415,751,891, and the highest MGNX revenue forecast at $20,415,751,891.

In 2026, MGNX is forecast to generate $6,555,892,253 in revenue, with the lowest revenue forecast at $6,555,892,253 and the highest revenue forecast at $6,555,892,253.

What is MGNX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MGNX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MGNX's Price Target?

According to 7 Wall Street analysts that have issued a 1 year MGNX price target, the average MGNX price target is $17.00, with the highest MGNX stock price forecast at $24.00 and the lowest MGNX stock price forecast at $12.00.

On average, Wall Street analysts predict that Macrogenics's share price could fall to $17.00 by Mar 4, 2025. The average Macrogenics stock price prediction forecasts a potential downside of 17.95% from the current MGNX share price of $20.72.

What is MGNX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MGNX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.